BRAIN Center Aims to Develop Innovative Technologies to Help Those with Neurological Diseases

Ana de Barros, PhD avatar

by Ana de Barros, PhD |

Share this article:

Share article via email
Parkinson's and brain stimulation

American scientists have formed what they call the BRAIN Center to develop, test and market innovative technologies to help people with neurological diseases such as Parkinson’s, stroke and paralysis, and people who have lost limbs.

The goal of BRAIN, which stands for Building Reliable Advances and Innovation in Neurotechnology, is to improve these patients’ functioning. The project’s partners include the National Science Foundation, Arizona State University and the University of Houston.

Demographics are one reason for the BRAIN Center, according to its website. The number of people 65 and older is projected to grow from an estimated 524 million now to nearly 1.5 billion in 2050.

In the United States, life expectancy is projected to reach 84.5 years by 2050. The average life expectancy in the country increased from 45 in 1900 to 78 in 2010, while birth rates dropped for the sixth consecutive year in 2014. Together, this combination will result in one in five Americans being 65 or older by 2050.

Increased life expectancy has changed the leading causes of disease and death. Today there are more chronic and degenerative diseases. That makes it imperative to develop innovative technologies that can address the disabilities associated with the diseases and lower healthcare costs.

Much of the world has basically moved from dying of fatal diseases to living with chronic diseases. So, the BRAIN Center wants to:

  • Revolutionize the treatment of brain disorders that limit mobility and cognition.
  • Change the way scientists and engineers approach the design of complex human-machine systems.
  • Understand brain function from the molecular to network level.
  • Capitalize on neuroplasticity to make human-machine interfaces more effective. Neuroplasticity is the brain’s ability to reorganize itself by forming new neural connections at different points in life.

An example of an innovative system would be one consisting of a closed-loop neuromodulation interface,  plus stimulation, sensing and imaging capabilities, to treat Parkinson’s and stroke. Another would be a virtual-physical human-machine interface. Still others would be integrated diagnostic and treatment systems.

One thing BRAIN researchers want to do is develop medical devices that interface with the nervous system to diagnose, monitor, treat and reverse movement disorders. They believe such devices will be a focus of industry innovation in coming years.

Key CENTER goals include developing technologies that:

  • Project 1 – Prevent falls among older people, and people with Parkinson’s and stroke.
  • Projects 2, 3 and 4 – Use brain-machine interfaces to address age-related and neural-disease-related sensory and movement problems.
  • Project 5 – Improve upper- and lower-extremity function in stroke patients.

“The BRAIN Center is a way to bring together top faculty at both institutions to address critical challenges in the biomedical field,” Jose Luis Contreras-Vidal, professor of electrical and computer engineering at the University of Houston, said in a press release. “The best way to do that is working with industry.”

“Medical advances have dramatically increased life expectancy in the 21st century,” said Marco Santello, director of Arizona State University’s School of Biological Health Sciences, who will lead the project. “The BRAIN Center will enable us to develop safe, reliable neurotechnologies to address the rise in chronic, degenerative diseases associated with an aging population.”

The center will receive a $1.5 million grant from the National Science Foundation that will go partly to training a new workforce. The focus will be on recruiting and training students from underrepresented communities in undergraduate programs related to the center’s efforts.

“We are training the next workforce,” Contreras-Vidal said. “The technology is so new, we don’t have enough people to design, repair, validate and prescribe these technologies.”